Neubotulinum Toxin Injection in Cerivical Dystonia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
24-Week Prospective, Double-Blinded, Randomized, Cross-over design in Multicenter Study of 50 unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A (Neuronox) injection for Cervical Dystonia in patient diagnosed with cervical dystonia according to clinical diagnosis. It was designed to evaluate the efficacy, safety, tolerability, quality of life and the comparesion the improvement after treatment by of 50 unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A (Neuronox) injection.
Epistemonikos ID: 097c36f3ce0f3cb6187841014b733eaff3948af2
First added on: Jan 28, 2022